France· FR:63564808
ALMOGRAN 12,5 mg, comprimé pelliculé
A medicinal product containing d,l-hydrogénomalate d'almotriptan, registered in France by ALMIRALL, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- D,L-HYDROGÉNOMALATE D'ALMOTRIPTAN
- Manufacturer
- ALMIRALL
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 2
2 priced- cip133400935561466plaquette(s) thermoformée(s) aluminium de 6 comprimé(s)EUR 6.58
- cip133400935860705plaquette(s) thermoformée(s) aluminium de 12 comprimé(s)EUR 13.11
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
D,l-hydrogénomalate d'almotriptan in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainALMOGRAN 12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULAAlmirall S.A.
- ItalyALMOGRANBB FARMA S.R.L.
- FinlandAlmogranAlmirall SA
- SwedenAlmogran 12,5 mg Filmdragerad tablett2care4 ApS
- PolandAlmozenDelfarma Sp. z o.o.
- NetherlandsAlmogran 12,5 mg filmomhulde tablettenOriginalis B.V.
- BelgiumAlmogran 12.5 mgOrifarm
- NorwayAlmogranAlmirall, S.A.
Authorised across Europe · EMA
The same active substance is authorised in 14 EEA countries. Names it is sold under:
- Belgium · Almogran
- Germany · Almogran, Almotriptan Bei Migräne Heumann
- Spain · Almogran, Almotriptán Cinfa
- Finland · Almogran
- United Kingdom (Northern Ireland) · Almogran, Almotriptan Accord-Uk
- Greece · Almogran
- Ireland · Almogran
- Italy · Almogran, Almotrex
- Luxembourg · Almogran
- Netherlands · Almogran
- Norway · Almogran, Almotriptan Orifarm
- Poland · Nomigren, Trymigan
- Portugal · Almogran, Almotriptano Galenicum
- Sweden · Almogran, Almotriptan Orifarm
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ca8649f4-7c2a-4bc7-988e-74cc2910c1b3 GET /v1/drugs/ca8649f4-7c2a-4bc7-988e-74cc2910c1b3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "63564808",
"date_amm": "2000-11-27",
"type_amm": "Procédure de reconnaissance mutuelle",
"numero_ue": null,
"substance": "D,L-HYDROGÉNOMALATE D'ALMOTRIPTAN",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé pelliculé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about d,l-hydrogénomalate d'almotriptan.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.